Xarelto 2-0

The jury for a second time, consecutively, ruled in favor of the defendants, J&J and Bayer, in the Xarelto Lawsuit trial. The defendant came in strong stating that the death of the plaintiff was caused due to several other underlying conditions and not Xarelto. This verdict has further strengthened the manufacturer's count and would require a thorough preparation by the plaintiffs and their legal aid in the upcoming lawsuits. The next hearing is scheduled for this August, in Mississippi.


We are social:

Accreditations

HIPAA

Neural IT has successfully implemented HIPAA for securing Health records....

ISO 27001 Certification

Neural IT has successfully passed the ISMS re-certification audit and is now ISO 27001:2013 certi...

NSIC - CRISIL

NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

Associations

CAALA

CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

CAOC

CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...

NYSTLA

NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...

News & Events

Hurricane Relief Fund
We donated to Hurricane Relief Fund and got a signed ball from Kareem Abdul-Jabbar, the greatest
AAJ Annual Convention 2017
Neural IT sponsored TRT meeting was one of the active participants of AAJ Annual Convention 2017.
NJAJ Boardwalk Seminar 2017
Neural IT exhibited at the NJAJ Boardwalk Seminar 2017 held at Harrah's Resort, Atlantic City, NJ

Latest Tweets